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Introduction. Pregnant women are at a high risk of anaemia, with iron-folate deficiency being the most common cause of anaemia
among pregnant women. Despite the well-known importance of iron and folic acid supplementation (IFAS) during pregnancy,
adherence to these supplements is relatively low and associated factors were not well identified in the study area. This study is
aimed at investigating adherence to IFAS and associated factors among pregnant women in Kasulu district, north-western
Tanzania. Methods. A health facility cross-sectional survey with a mixed-method approach was conducted in Kasulu district
from March to April 2019. A structured questionnaire was given to 320 women with children aged 0-6 months to assess factors
associated with adherence to IFAS among pregnant women. Data were entered into SPSS version 22.0 for analysis. Binary
logistic regression was further employed to determine the factors associated with adherence to IFAS. Focus group discussions
were done with 19 pregnant women and 15 mothers of children aged 0-6 months to obtain more clarifications on the factors
associated with adherence to IFAS. Furthermore, in-depth interviews were done with six health care providers to explore their
perceptions of IFAS. Results. Out of the 320 respondents of the survey, 20.3% (n = 65) adhered to IFAS. Factors associated with
adherence to IFAS among pregnant women included time to start ANC (AOR = 3:72, 95% CI: 1.42, 9.79), knowledge of
anaemia (AOR = 3:84, 95% CI: 1.335, 10.66), counseling on the importance of the iron-folic acid (AOR = 3:86, 95% CI: 1.42,
10.50), IFAS given during clinical visit (AOR = 15:72, 95% CI: 5.34, 46.31), number of meals consumed (AOR = 3:44, 95% CI:
1.28, 9.21), number of children (AOR = 3:462, 95% CI: 1.035, 11.58), and distance to health facility (AOR = 0:34, 95% CI: 0.131,
0.886). Qualitative findings revealed that delayed first ANC visit, lack of remainder for pregnant women to take IFAS, low
awareness about the negative effects of anaemia, low of knowledge of IFAS and management of side effects, negative beliefs
about the use of IFAS, and follow-up mechanism were major reasons for poor adherence. Conclusion. Adherence to iron-folic
acid supplementation during pregnancy was low. Strengthening systems for creating reminding mechanism, raising community
awareness through educational programs to pregnant women and health providers could improve adherence to IFAS.
1. Introduction
Anaemia affects more than two billion people, 30-50% of
whom are from developing countries including Tanzania
[1]. Nearly 50% of all anaemia can be attributed to iron defi-
ciency [1, 2]. Folic acid is also a vital micronutrient required
for the metabolism, foetal growth, and the development of
the neural tube [3]. Globally, the estimated prevalence of
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anaemia among nonpregnant and pregnant women was
29% and 38%, respectively, whereas, in Africa, the estimated
proportions were 37.8% and 46.3%, respectively [2]. In
Tanzania, the burden of iron deficiency accounts for approx-
imately 57% among pregnant mothers and 46% among
breastfeeding mothers [4]. Similarly, the prevalence of anae-
mia among women of reproductive age between 15 and 49
years is 45% in Tanzania and Kigoma region alone dispro-
portionately carrying over half (55.1%) of the burden [4].
Pregnant women are more vulnerable to anaemia
because of various factors. These include biological changes
(menstrual period), undernutrition attributed to poverty,
food insecurity, gender inequalities, inadequate knowledge
of proper dietary practices, and increased iron and folic acid
deficiency [5]. Furthermore, pregnant women experience
increased micronutrient demand especially iron for the
growth of foetus and metabolism which cannot be easily
met by diet alone because of the poor intake and low absorp-
tion of iron [3].
Women who failed to consume the tablets according to
the IFAS recommendation would experience iron and folic
acid (IFA) deficiency anaemia and associated negative effects
on mothers and newborns. Folic acid deficiency in pregnant
women is associated with preeclampsia and, preterm deliv-
ery. It is also related to neural tube defects, foetal malforma-
tion, type 2 diabetes, and obesity in the newborn [6–8].
Similarly, iron deficiency anaemia is connected with mater-
nal risks including haemorrhage, premature delivery, rupture
membrane, decreased work capacity, and maternal deaths.
Correspondingly, small for gestational age, low birth weight,
poor cognitive development, stillbirth, and cardiovascular
disease were risks associated with iron anaemia in the
newborn [2, 9, 10]. Anaemia leads to approximately
50,000 deaths during childbirth each year globally [9]
and iron deficiency alone accounts for 22% of all anaemia
deaths [7]. In sub-Saharan Africa, anaemia contributed to
approximately 28.6% of maternal deaths [11] and 10% in
Tanzania [12].
The World Health Organization (WHO) recommends
uptake of iron and folic acid supplement during pregnancy
for at least six months [13]. Tanzania adopted the WHO rec-
ommendation and requires all pregnant women to consume
30-60mg of a dose of iron and 400μg of folic acid daily start-
ing early at first antenatal visit [2, 4, 13]. Despite the national
guideline emphasis, adherence to iron-folic acid supplements
during pregnancy is still low [4].
The proportion of pregnant women who reported to
uptake iron and folic acid supplementation in Tanzania for
at least 90 days was less than a quarter (21%) with only 7%
in Kigoma region [4]. IFAS is considered the best strategy
to control anaemia during pregnancy, but low adherence to
IFAS compromises the effectiveness of this strategy [4].
Based on these facts, describing adherence to IFAS and asso-
ciated factors among pregnant women would be the potential
for evidence-based interventions.
Moreover, various studies have been conducted in
Tanzania about IFAS; however, the majority of these focused
on the effects of IFAS in newborn and pregnant women and
only limited studies assessed the adherence to IFAS and
associated factors among pregnant women. With these inad-
equate studies, the available data may also be outdated.
Currently, studies conducted on IFAS in Kasulu district are
limited. Therefore, this study is aimed at assessing adherence
to IFAS and associated factors in the Kasulu district in
north-western Tanzania.
2. Methods and Materials
2.1. Study Design and Study Area. A health facility-based
cross-sectional study using a mixed-method approach was
conducted in Kasulu district in Kigoma region, 4°44′0° S
and 30°44′0° E Tanzania from March to April 2019 [14].
The district has two administrative areas with a total popula-
tion of 634,038 people [15]. Kasulu district is predominately
occupied by the “Waha” ethnic group. The main activities are
subsistence and small-scale farming and medium-scale busi-
ness, particularly in Kasulu town. The other tribe found in
the district is Sukuma, who engaged in pastoralism activities
[14]. The average of pregnant women registered in Kasulu
district per year was 38,951, and nearly three quarters were
from Kasulu rural. A total of 34,365 of women with children
aged 0-6 months were also recorded, and over seventy per-
cent were from Kasulu rural.
2.2. Study Population. The study population consisted of
health care providers, pregnant women, and mothers with
children aged 0-6 months, who attended antenatal clinic
(ANC) and postnatal services during the study. Women with
children aged 0-6 months, attended ANC visits during their
last pregnancy, and supplied with IFAS were included in
the quantitative study. The qualitative study involved preg-
nant women, women with children aged 0-6 months, and
health care providers working at the reproductive and child
health department. Health care providers and all mothers
came from two health facilities in Kasulu district; these were
Kasulu Hospital (KH) and Kiganamo Health Center (KHC).
All women with children aged 0-6 months who did not attend
ANC visit during pregnancy, all women having less than three
ANC visits, and all women who were not supplied with IFAS,
unable to speak/hear, or with mental disorders were excluded
from the study. Detailed information in Figure 1.
2.3. Sample Size and Sampling Procedures. A total of 320
mothers of children aged 0-6 months were included in the
study. The sample size was determined based on a single pop-
ulation proportion formula ðZ2Pð1 − PÞ/ðeÞ2Þ with a 95% Cl,
5% margin error (Zα/2 = 1:96) by considering the national
adherence to IFAS (P = 21%) [4] at 80% desired power (Bα)
and 10% of the estimated nonresponse rate. Nonresponse
was considered to maximize the sample size of 320 study
respondents.
Mothers of children aged 0-6 months were systematically
sampled from a list of clients attending postnatal services in
the two facilities. These included Kasulu Hospital and
KiganamoHealth Center which are well known to accommo-
date and provide maternal services to a large number of preg-
nant women compared to other health facilities in Kasulu
town. This study was done between March and April 2019.
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In addition, 40 respondents were purposively selected and
involved in a qualitative study. These included six health care
providers who participated in in-depth interviews (IDIs), 19
pregnant women, and 15 mothers with children aged 0-6
months who participated in focus group discussions (FGDs).
A total of four FGDs were conducted of which two comprised
of pregnant women and two comprised of mothers of chil-
dren aged 0-6 months. Each FDG included 7-11 respondents.
2.4. Data Collection Procedures and Quality Control. A struc-
tured questionnaire established based on information from
Tanzania Demographic Health Survey (TDHS) and pub-
lished articles was administered to women who had children
aged 0-6 months [4, 16–18]. The structured questionnaire
captured sociodemographic information, maternal factors,
health facility factors, household factors, medication factors,
access to health care, perception of the quality of services,
knowledge of anaemia, knowledge of IFAS, and adherence
to IFAS. All tools were developed in English and translated
into Swahili (a local language) for simplicity and under-
standing and then back-translated to English by language
researchers conversant in both languages to facilitate consis-
tency. Data collectors and supervisors were trained on the
objectives, how to keep confidential information, and filling
of information. Tools were pretested, and all necessary
changes were made before the start of actual data collection.
An interview guide was used for the focused group discussion
and in-depth interviews.
2.5. Operational Definition
2.5.1. Adherence to IFAS. Adherence to IFAS was self-
reported and assessed by considering the total numbers of
IFAS tablets consumed during their last pregnancy. Pregnant
women were recommended to consume one tablet of iron
and folic acid tablets containing 30-60mg of iron and
Kasulu district
Systematic random sampling
A total of 320 were interviewed 
as final sample size
128 -Kasulu Hospital
192 -Kiganamo HC 
24 participants were not eligible
Women with children of above 6 months (n = 19)
Not attended ANC during pregnancy (n = 5)
983 = eligible for quantitative study
295 - Kasulu Hospital
668 - from Kiganamo HC
Nonresponse (partially)
2 -Kasulu Hospital






1007-all participants from the 2 facilities
302 -Kasulu Hospital
705 -Kiganamo HC
Figure 1: Participants’ flow diagram.
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400μg of folic acid daily for at least 90 days [2, 4, 13]. Six
questions were added together to assess adherence to IFAS.
These include information about the number of ANC visits,
the number of sachets given in each visit, and the total
number of tablets given for the whole period of pregnancy.
The number of tablets consumed and remaining before
childbirth was also recorded. All women who took tablets
for at least 90 days were considered to adhere to the IFAS
program and vice versa.
2.5.2. Knowledge of Anaemia. The knowledge of anaemia
was assessed by adding up the four multiple-choice items
including causes, symptoms, consequences, and prevention
methods of anaemia. The correct answer was labeled, and
the wrong answer was not labeled. Answers were catego-
rized into two groups; those who scored medium and
above were considered to have high knowledge and low
knowledge when scored below medium.
2.5.3. Knowledge of Iron-Folic Acid Supplementation. To
understand the knowledge of IFAS among respondents, six
multiple-choice questions were added together including
physical appearance (color), time to start using IFAS, the rec-
ommended number of tablets, benefits of IFAS, and negative
effects to mothers and children when the adequate tablets
were not consumed. The correct answer was labeled, and
the wrong answer was not labeled. Answers were classified
into two groups and labeled high knowledge if scored
medium and above and low knowledge of IFAS if scored
below medium.
2.5.4. Perception of the Quality of Services. To measure per-
ception, five multiple-choice questions were added up
including the number of tablets provided, general physical
checkup, service satisfaction, being given IFAS for free, and
customer care. The answer was ordered into two groups
and labeled positive perception when scoring medium and
above and negative perception when scoring below medium.
2.6. Data Processing and Analysis. Quantitative data were
checked, coded, and entered into SPSS software version 22
with a statistical significance decided at P value < 0.05.
Descriptive analysis, including frequencies, percentages,
and chi-square testing, was employed when determining
the association among variables and adequacy of cells. A
binary logistic regression model was fitted after multicolli-
nearity diagnosis to establish factors to IFAS adherence.
Adjusted odds ratio (AOR) with 95% CI, P value < 0.05
was considered statistically significant.
The recall bias was managed through interviewing the
mothers who gave birth within a short time, six months prior
to the study (women with children aged 0-6 months).
Also, a sachet of iron and folic acid supplementation was
demonstrated to mothers during the interview to aid their
memories.
All audio records from qualitative interviews were tran-
scribed and translated to English before analysis. The authors
transcribed each discussion verbatim and carefully checked
each transcript for accuracy by simultaneously listening to
the audio recording and reading transcript. Notes taken dur-
ing the discussions or interviews were incorporated in the
final transcripts. Data were coded and analyzed using NVIvo
software version 10. Thematic analysis was employed to
explore the themes raised during focus group discussions
and in-depth interviews. Finally, the themes that stemmed
from both FGD and IDI were triangulated with quantitative
findings.
2.7. Ethical Consideration. Ethical clearance and approval of
the study were obtained from Ifakara Health Institute Review
Board on 9th February 2019 (IHI/IRB/No: 9-2019). Introduc-
tion letter from the Department of Research and Training of
Ifakara Health Institute was also provided to investigators.
The study team made a courtesy visit to the district adminis-
tration prior to data collection. Furthermore, the purpose of
the study was explained to all respondents and written
informed consent forms were provided and signed before
the interview. The verbal consent was also enquired before
the group discussion. The informed consent was read to
respondents loudly in front of the witness. Respondents
who were unable to read and write were asked to sign using
a thumb fingerprint before the study. The confidentiality of
their information was assured among respondents.
3. Results
3.1. Social and Demographic Characteristics of Women with
Children Aged 0-6 Months. The summary of the sociodemo-
graphic information of the respondents is provided in
Table 1. Of the 320 respondents of the survey, 128 were from
Kiganamo Health Center and 192 from Kasulu Hospital. A
majority of the respondents were aged 15-24 years 140
(43%).More than half of the respondents (53.75%) completed
primary education, and nearly three quarters (n = 232, 72.5%)
were not employed in formal sectors (Table 1).
3.2. Knowledge about Anaemia. Out of 320 respondents, two
hundred twenty-two (69.4%) had high knowledge of anae-
mia. The findings from qualitative study concerning the
causes of anaemia were thought to be sitting under the sun,
infectious diseases (malaria, UTI, HIV, and worms), poor
diet, and inadequate consumption of vegetables and fruits.
The symptoms of anaemia include dizziness, fatigue, feeling
sick, and edema. The majority of respondents found that
the consequences of anaemia among pregnant women were
death attributed to bleeding during childbirth and miscar-
riage. On the other hand, health care providers had different
understanding regarding the meaning of anaemia in preg-
nant women. Anaemia in pregnant was implied when Hb
was below 7.5mg/l, and others said pregnant women were
considered to have anaemia when Hb was below 12mg/l.
3.3. Knowledge of Iron-Folic Acid Supplementation (IFAS).
Awareness of IFAS among women with children aged 0-6
months was demonstrated by attending antenatal clinics.
Among all respondents, less than half (n = 110, 34.4%) had
high knowledge of IFAS and were primarily received during
the ANC visit. A total of two hundred fifty-nine (80.9%)
women had an understanding that IFAS increases blood level
during pregnancy. Similarly, seventeen women (5.3%) had
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knowledge of IFAS that it works best to improve the health of
the newborn. Qualitative findings revealed that a belief on
IFAS to increase blood level influenced the women’s adher-
ence to IFAS. It was also reported that deaths and abnormal-
ities like neural tube defects among newborns were reduced
when IFAS is consumed properly during pregnancy. On the
other hand, pregnant women built trust in the performance
of health care providers. In the same manner, both women
and health care providers had low awareness about the tim-
ing of starting IFAS. Further, the time spent to educate
women about the importance of IFAS was not enough (30
minutes) as quoted below:
“We could not provide a detailed explanation to pregnant
women; we often tell them, IFAS prevents you from giving
birth to a child with a big head, but when asked how it works,
it becomes difficult to explain because we have no further
information”. …..She emphasized, “We need to update our
knowledge” (a health care provider at KH).
3.4. Factors Related to Adherence to Iron-Folic Acid
Supplementation among Pregnant Women. Over ninety per-
cent of respondents (n = 296) were given IFAS from two
clinics, and the adherence to IFAS was 20.3% (n = 65). The
reasons related to poor adherence were delayed initiation of
ANC, distance to the health facilities, availability of IFAS,
perceived quality of health facility services, being healthy,
women’s experiences with multiple births, misconception
about pregnancy and IFAS, lack of knowledge on the benefits
of IFAS, negligence, forgetfulness, and side effects, including
nausea, dizziness, and vomiting. See the quote below:
“If not sick, why should we take it”. “….we were also told
by women in our communities that, whoever takes IFAS,
experiences more bleeding during delivery and gave birth to
blaze skinny babies” (FGD: women with a child aged 0-6
months at KHC).
3.4.1. Timing of ANC Services. Most of the women, approxi-
mately two hundred and seventeen (67.8%), started the first
antenatal clinic (ANC) visit during the second or third
trimester (Table 2). Delayed ANC attendance was associated
with women’s perception. Attending to ANC early was
attributed with the negative perception that woman was
weak, fear of being pregnant, and pregnancy was designated
as secret. It was also associated with notion around HIV test-
ing to both partners as part of prevention of mother-to-child
transmission (PMTCT) program accompanied by partners
to attend ANC as quoted below:
“We want to be sure of what is inside the womb by sens-
ing fetal movement first before going to the clinic for the first
visit because if you go early many will laugh at you and say
it’s like you are making an advertisement that you have preg-
nant, it is a show up” (FGD: women with children aged 0-6
months at KH).
During the discussion, a prime woman with the age of 28
years emphasized that the PMTCT program and related
attributes were associated with delayed ANC visits.
“The first time I came to the clinic, I found a case of preg-
nant women who came with a motorcycle driver acting to be
her husband. After testing for HIV, a driver was infected.
During the counseling session, a pregnant woman confirmed
that a man was not her husband. Therefore, this strategy puts
pressure on women leading them to tell lie and delay to
attend ANC services” (FGD: pregnant women at KH).
3.4.2. Distance to the Health Facility. Distance was estimated
by using the time spent from residents to the health facility.
Over half of the women spent 30 minutes or less to reach the
health facility (n = 172, 53.8%), and one hundred forty-eight
respondents spent 60 minutes and above (46.2%) as presented
in Table 2. On the other hand, the cost of transportation is
attributed between 1000 and 3000 Tshs per each ANC visit.
The challenge of distance to attend ANC during pregnancy
was also revealed from qualitative findings as quoted below:
“Please help us to have a clinic close to residential areas, it
is difficult for a pregnant woman to walk more than one hour
to access ANC services” (FGD: pregnant women at KHC).
Table 1: The sociodemographic characteristics of respondents in Kasulu district, north-western Tanzania, March-April 2019 (N = 320).
Variables Categories Frequency (n) Percent (%)
Mothers age (years)
15-24 years 140 43.8
25-34 years 121 37.8
35-49 years 59 18.4
Mothers education
No formal education 69 21.5
Completed primary 172 53.8
Completed secondary + 79 24.7
Mothers occupation
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3.4.3. Support from a Partner. Nine percent (n = 28) of
women reported being reminded by their husband about
taking IFAS during pregnancy (Table 2). A similar finding
was reported in the qualitative data as quoted below:
“How do they remind us when they do not understand its
benefits…, they even not bother…, they don’t care…, they
are less concerned” (FGD: pregnant women at KH).
3.4.4. Perception of the Health Services. Nearly three-quarters
of the women (n = 230, 71.9%) had a positive perception of
health services provided at health facilities (Table 2). A
majority of the respondents perceived the quality of services
provided at both health facilities to be good. Challenges
reported were much time spent at the ANC that was attrib-
uted to the large number of women presented at each visit
and an inadequate amount of tablets provided at each visit
that sometimes was not enough to meet the next visit. It
was also reported that being instructed to come with partners
at ANC during the first visit was another challenge thought
by respondents. These were different to health care providers;
challenges of the IFAS program and services were attributed
with a few staffs and poor working environment as quoted
below:
“IFAS does not belong to anybody, because other services
like malaria, family planning, and HIV have special people
working closely with the ANC and community to ensure
the community understands better. No effort has been put
in place to advocate on the importance of IFAS in and out
of clinics” (a health care provider at KH).
3.4.5. Availability of IFAS. IFAS was provided at ANC for
free; however, forty percent (n = 128) of the respondents
attended ANC visits only were given IFAS on each visit.
Women who were provided 90 IFAS tablets or more was
low compared to the women who were given IFAS during
their ANC visit (n = 296, 92.5%) with frequently IFAS stock
out in health facilities.
3.5. Factors Associated with Adherence to Iron-Folic Acid
Supplementation (IFAS) among Pregnant Women Attended
ANC Services. In this study, IFAS given in each visit, knowl-
edge of IFAS, knowledge of anaemia, gestation period at first
ANC visit, the number of meals, and number of children
Table 2: Characteristics related to supplementation among respondents in Kasulu district, north-western Tanzania, March-April 2019
(N = 320).
Variables Categories Frequency (n) Percent (%)
Distance to the health facility (minutes)
0-30 minutes 172 53.8
60+ minutes 148 46.2
Number of children
1-3 children 221 69.1
4+ children 99 30.9
Time at first ANC visit
0-3 months 103 32.2
4-6 months 197 61.6
7-9 months 20 6.2
Access to IFAS
ANC 296 92.5
Not ANC 24 7.5
IFAS given each visit
Yes 128 40
No 192 60
Reminded by a husband to take IFAS
Reminded 28 8.8
Not reminded 292 91.3
Side effects
Side effects 108 33.8
No side effects 212 66.2
Knowledge of anaemia
High knowledge 222 69.4
Low knowledge 98 30.6
Knowledge of IFAs
High knowledge 110 34.4
Low knowledge 210 65.6
Time spent to educated IFAS
Enough 92 28.8
Not enough 228 71.2





No adherence 255 79.7
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were the factors associated with adherence of IFAS among
pregnant women. The details on the associated factors of
IFAS are shown in Table 3.
4. Discussion
In this study, the adherence to IFAS was low among preg-
nant women and factors associated with adherence to
IFAS were included: the knowledge of anaemia, knowledge
of IFAS, time a woman attended at ANC visit, number of
IFAS tablets provided, number of meals, number of chil-
dren, and distance to the health facility. Details are found
in Table 2.
The result of adherence to IFAS in this study was consis-
tent with national adherence (21%) [4]. Similarly, studies
conducted in Kiambu, Kenya (32.7%), and Amhara, Western
Ethiopia (20.4%), also found the low adherence to IFAS
among pregnant women [19, 20]. Also, adherence to IFAS
was modestly higher compared to the studies conducted in
Eastern Kenya (18.3%), Uganda (12%), Norway (16%), and
Northern Tanzania (16.1%) [21–24] and lower compared to
studies conducted in Senegal (51%), Kathmandu-Nepal
(73.2%), Tamil Nadu-India (60.6%), and Mizan-Aman-
Ethiopia (70.6%) [25–28]. Some of the probable reasons of
inconsistency might be a different study subject, sociodemo-
graphic characteristics, locality, follow-up and reminding
mechanism, knowledge of IFAS, and qualities of health ser-
vices offered in the health facilities including counseling on
its benefits, the average number of IFAS recommended dur-
ing pregnancy, and belief on the use of IFAS.




COR (CI at 95%) AOR (CI at 95%)
Adhered N (%) Not adhered N (%)
Distance to the health facility (minutes)
60+ minutes 27 (16.77) 134 (83.23)
1.271 (0.732, 2.205)
0.338 (0.131, 0.886)∗
0-30 minutes 38 (23.90) 121 (76.1) 1
Number of ANC visits
4+ 49 (24.62) 150 (75.38)
0.466 (0.256, 0.865)
0.6106 (0.220, 1.692)
Less than 4 16 (13.22) 105 (86.78) 1
Knowledge of IFAS
High knowledge 35 (31.82) 75 (68.18)
2.80 (1.604, 4.890)
3.864 (1.422, 10.500)∗
Low knowledge 30 (14.29) 180 (85.71) 1
Knowledge of Anaemia
High knowledge 56 (38.62) 89 (61.38) 3.336 (1.577, 7.059) 3.840 (1.335, 10.685)∗
Low knowledge 09 (5.14) 166 (94.86) 1
IFAS given each visit
Given each visits 52 (40.62) 76 (59.38)
9.421 (4.848, 18.307)
15.718 (5.335, 46.311)∗
Not given each visits 13 (6.77) 179 (93.23) 1
Number of meals
Twice and below 49 (28.32) 124 (71.68)
3.385 (1.721, 5.894)
3.439 (1.284, 9.212)∗
Three times or more 16 (10.88) 131 (89.12) 1
Time at first visit
1st trimester 33 (32.04) 70 (67.96)
2.725 (1.559, 4.765)
3.724 (1.417, 9.791)∗
2nd+ trimester 32 (14.75) 185 (85.25) 1
Side effect
Side effects 12 (11.11) 96 (88.89)
0.375 (0.191, 0.757)
0.132 (0.043, 0.406)
No side effects 53 (25) 159 (75) 1
Reminded by husband
Yes 55 (18.84) 237 (81.16)
2.394 (1.047, 5.473)
1.157 (0.454, 2.946)
No 10 (35.71) 18 (64.29) 1
Number of children
Less than 4 children 57 (25.79) 164 (74.21)
3.185 (1.807, 8.651)
3.462 (1.035,11.582)∗
4+ children 8 (8.08) 91 (91.92) 1
AOR = adjusted odds ratio; CI = confidence interval; COR = crude odds ratio; ∗statistically significant; 1 = reference. Note Hosmer and Lemeshow Test = 0:925;
therefore, the model is fitted to predict the factors associated with adherence.
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The findings of this study indicated that women who had
high knowledge of IFAS were 3.9 times more likely to adhere
to the IFAS program compared to the women who had low
knowledge. The study was reliable with the studies conducted
in Northern Wollo, Ethiopia, and Misha district, Ethiopia
[29, 30]. The time spent to counsel pregnant mothers about
the benefits of IFAS, consequences of not using IFAS, proper
prescription, and awareness of side effect management were
the reasons for adherence to the IFAS program.
Women with high knowledge of anaemia were 3.8 times
more likely to adhere to the program compared to women
with low knowledge of anaemia. This was consistent with
studies conducted in Aykel, Ethiopia, and Nepal [26, 31].
The probable reasons for adherence might be the proper
counseling about the prevention measures, consequences of
anaemia at ANC, and availability of media used to create
awareness in communities.
Similarly, women provided with IFAS tablets in each
visit were 15.7 times more likely to adhere to the program
compared to women who were not provided with IFAS
each visit. These findings corroborated with studies con-
ducted in Mizan-Aman, Ethiopia, and Pakistan [28, 32].
Studies conducted in Uganda, Pakistan, and South Africa
found that less supply of IFAS had low adherence to IFAS
[24, 32, 33]. Other studies conducted in Ismailia govern-
ment and Assela town-Ethiopia reported that crowding
of tablets was associated with the low adherence to supple-
mentation [34, 35]. The reasons might be associated with
the availability of tablets at ANC, the number of ANC
visits, knowledge of health care providers about time to
start IFAS, and awareness of the average number of IFAS
required for adherence.
Other studies have indicated that women with high
wealth quintile and eating three and above meals per day
were likely to adhere to IFAS compare to women from low
wealth quintile [36, 37]. However, in the present study,
women from the families eating twice or less were found to
be 3.4 times more likely to adhere to IFAS as compared to
women from the families who ate three times and more. This
was contrary to a study conducted in India, which showed
that women from households with high wealth quintile were
less likely to adhere to IFAS due to good health and able to
access them when needed [27]. The reasons might be educa-
tion level, occupation of women and their partners or house-
hold income, location, and verse versa.
The time to start ANC visits was associated with adher-
ence to the IFAS program. The present study revealed that
women who attended ANC visit in the first trimester were
likely to adhere to the IFAS program 3.7 times more com-
pared to those who started ANC visit in the second trimester
and third trimester. This was consistent with studies con-
ducted in North Wollo Zone-Ethiopia, Ibadan-Nigeria,
Bangladesh, and Tamil Nadu-India, which reported that
early registration in the first and second trimester has a pos-
itive effect to adherence to IFAS program than in the third
trimester [16, 27, 29, 38]. The possible reasons for adherence
might be the knowledge on the time to start ANC, beliefs,
perception, distance to the health facility, and delayed ANC
visit attributed to HIV testing to both women and their part-
ners. This might affect directly the duration and number of
tablets consumed to adhere to the IFAS program.
In this study, women with 1-3 children were 3.5 times
more likely to adhere to the program compared to women
with 4 and above children. This was consistent with studies
conducted in India and Tanzania, which showed that women
with two children and below were likely to adhere to the pro-
gram compared to women with more children [21, 39].
According to a study conducted in Assela town, Ethiopia, it
was reported that having fewer children had less likely to
adhere compared with women with more children [35].
The probable reasons for adherence to IFAS could be the
maternal-related experience. Studies conducted in Debre
Tabor-Ethiopia and Ismailia government reported that gra-
vidity had an association with adherence to IFAS [17, 34].
The distance from residential to the health facilities was
associated with adherence to the IFAS program. Women liv-
ing 60 minutes or more from the health facilities were less
likely to adhere to the IFAS program 0.34 times compared
to the women living near the health facilities. In other studies,
women who were living close to health facilities or private
pharmacies had more chance to adhere to the IFAS program
more times compared to women who were living far from
health facilities [25, 36, 40]. The reasons might be the lack
of close health facilities and less economic index; less
availability of pharmacies used to sell IFAS and negligence
among mothers were the reasons for low adherence to the
IFAS program.
The other reasons for low adherence to IFAS were
revealed from the qualitative analysis including women’s
experiences, lack of knowledge about the benefits of IFAS,
negligence, forgetfulness, and the side effects including
nausea, dizziness, and vomiting. The other reason was misin-
formation about pregnancy and misperception around the
IFAS, including giving birth to a child with burned skin. It
was also reported that the majority did not consume IFAS
if they were feeling healthy and become less motivated. This
study corroborates with the study conducted in Ethiopia
[41, 42]; however, the other studies reported that fear of
being sick or being sick was associated with adherence to
the IFAS program [21, 26, 28, 43]. On the other hand, misin-
formation included fear to give birth to big baby, spot-on
teeth of children and face of mothers, difficult delivery, not
beneficial to babies, mothers experience with no history of
having children with neural tube defects, and more bleeding
during delivery was associated with low adherence to IFAS
[10, 20, 33, 35, 44]. Regarding forgetfulness, the study was
consistent with various studies conducted in various regions
including Kenya, Vietnam, Pakistan, Ethiopia, and Iran
[23, 32, 43, 45, 46].
4.1. Limitation of Study. The study had its limitations and
needs to be considered during the interpretation of the
results. First, adherence to IFAS was determined by self-
report which might affect the actual adherence due to the
possibility of over- or underreporting of ingested tablets. Sec-
ond, pill counts and measuring of haemoglobin concentra-
tion and biomarkers may predict better the adherence to
IFAS; however, it was not done in this study.
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5. Conclusion
Adherence to iron and folic acid among pregnant women
was low. Factors associated with adherence to IFAS included
time to start ANC, knowledge of anaemia among women,
counseling on the importance of the iron-folic acid, number
of IFAS provided each visit, and number of children. How-
ever, the side effects and distance to the health facility had
less effect on adherence to IFAS. Therefore, the prevention
of iron-folic acid deficiency through strengthening the
system to create community awareness; health promotion
and counseling; education programs among health care pro-
viders, males, and pregnant women; and reminding mecha-
nisms is paramount to improve adherence to IFAS.
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